4/A//SEC Filing
Martin Tami Tillotson 4/A
Accession 0001104659-23-044664
CIK 0001356576other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 5:00 PM ET
Size
9.2 KB
Accession
0001104659-23-044664
Insider Transaction Report
Form 4/AAmended
Martin Tami Tillotson
VP of Regulatory Affairs
Transactions
- Tax Payment
Common Stock
2023-02-22$38.57/sh−289$11,147→ 90,034 total - Disposition to Issuer
Restricted Stock Units
2023-02-22−750→ 2,250 total→ Common Stock (750 underlying) - Award
Common Stock
2023-02-22+750→ 90,323 total
Footnotes (4)
- [F1]Includes an aggregate of 853 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
- [F2]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
- [F3]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F4]These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001539494
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 5:00 PM ET
- Size
- 9.2 KB